111 Revenue 2018-2026 | YI

111 revenue from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
111 Annual Revenue
(Millions of US $)
2025 $1,795
2024 $1,973
2023 $2,105
2022 $1,960
2021 $1,950
2020 $1,257
2019 $568
2018 $260
2017 $145
111 Quarterly Revenue
(Millions of US $)
2026-03-31 $342
2025-12-31 $440
2025-09-30 $422
2025-06-30 $448
2025-03-31 $486
2024-12-31 $500
2024-09-30 $513
2024-06-30 $471
2024-03-31 $489
2023-12-31 $585
2023-09-30 $502
2023-06-30 $480
2023-03-31 $538
2022-12-31 $565
2022-09-30 $471
2022-06-30 $453
2022-03-31 $470
2021-12-31 $566
2021-09-30 $519
2021-06-30 $468
2021-03-31 $396
2020-12-31 $457
2020-09-30 $348
2020-06-30 $230
2020-03-31 $223
2019-12-31 $193
2019-09-30 $155
2019-06-30 $122
2019-03-31 $98
2018-09-30 $72
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.031B $1.795B
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription and other services. 111, Inc. is headquartered in Shanghai, China.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $43.014B 42.92
Tempus AI (TEM) United States $11.225B 0.00
10x Genomics (TXG) United States $9.135B 0.00
Hinge Health (HNGE) United States $7.649B 73.48
Hims & Hers Health (HIMS) United States $6.722B 0.00
Doximity (DOCS) United States $4.704B 29.00
Heartflow (HTFL) United States $4.308B 0.00
IRhythm Holdings (IRTC) United States $3.782B 249.39
Clover Health Investments (CLOV) United States $2.709B 0.00
Privia Health (PRVA) United States $2.667B 99.43
Inspire Medical Systems (INSP) United States $2.149B 32.74
Butterfly Network (BFLY) United States $1.973B 0.00
Schrodinger (SDGR) United States $1.532B 0.00
Omnicell (OMCL) United States $1.524B 21.76
Azenta (AZTA) United States $1.404B 76.29
Enovis (ENOV) United States $1.051B 5.44
Talkspace (TALK) United States $0.879B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.659B 0.00
Phreesia (PHR) United States $0.647B 34.73
Claritev (CTEV) United States $0.618B 0.00
Veradigm (MDRX) United States $0.593B 0.00
Fulgent Genetics (FLGT) United States $0.568B 0.00
Evolent Health (EVH) United States $0.464B 0.00
Carlsmed (CARL) United States $0.419B 0.00
Senseonics Holdings (SENS) United States $0.370B 0.00
CapsoVision (CV) United States $0.326B 0.00
Standard BioTools (LAB) United States $0.273B 0.00
American Well (AMWL) United States $0.230B 0.00
KORU Medical Systems (KRMD) United States $0.144B 0.00
Health Catalyst (HCAT) United States $0.137B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.132B 0.00
CareCloud (CCLD) United States $0.089B 6.53
Pulmonx (LUNG) United States $0.085B 0.00
Zepp Health (ZEPP) Netherlands $0.065B 0.00
Nyxoah SA (NYXH) Belgium $0.062B 0.00
P3 Health Partners (PIII) United States $0.060B 0.00
Outset Medical (OM) United States $0.059B 0.00
EUDA Health Holdings (EUDA) Singapore $0.050B 0.00
Precipio (PRPO) United States $0.049B 0.00
MDxHealth SA (MDXH) Belgium $0.035B 0.00
Evaxion - (EVAX) Denmark $0.026B 0.00
HeartBeam (BEAT) United States $0.023B 0.00
Predictive Oncology (POAI) United States $0.020B 0.00
HeartSciences (HSCS) United States $0.014B 0.00
Healthcare Triangle (HCTI) United States $0.011B 0.00
Lunai Bioworks (LNAI) United States $0.010B 0.00
Bullfrog AI Holdings (BFRG) United States $0.009B 0.00
ITonic Holdings (ITOC) China $0.005B 0.00
DataMeds AI (MEDS) United States $0.003B 0.00
Tivic Health Systems (TIVC) United States $0.003B 0.00
PROFUSA (PFSA) United States $0.002B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.001B 0.00
Zhongchao (ZCMD) China $0.001B 0.00
TruBridge (TBRG) United States $0.000B 0.00